TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06195462

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Laying on of hands with intention health (LHHI)
Description: The participants will receive systemic acupuncture. The no healers will move their hands in a longitudinal direction, starting at the top of the patient's head, slowly lowering their hands along the body, 5 times and asked to send thoughts of health and healing to the participant. Then, they will place their hands on the patient's head, distance about 10 to 15 cm, during 5 minutes. Weekly sessions.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laying on of hands by spiritist passe
Description: The participants will receive systemic acupuncture. The healers will prepare before the start with prayer for connection with Good Spirits and will move their hands in a longitudinal direction, starting at the top of the patient's head, slowly lowering their hands along the body, 5 times and asked to send thoughts of health and healing to the participant. Then, they will place their hands on the patient's head, distance about 10 to 15 cm, during 5 minutes. Weekly sessions.

Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: The participants will receive systemic acupuncture and they not receive the laying on of hands.
Study: NCT05245591

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pentosan Polysulfate Sodium 100 MG Oral Capsule
Description: Pentosan Polysulfate Sodium 100 mg three times daily (tid) for 0-8 weeks Pentosan Polysulfate Sodium 100 mg twice daily (bid) for 9-16 weeks

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo 100 mg three times daily (tid) for 0-8 weeks Placebo 100 mg twice daily (bid) for 9-16 weeks
Study: NCT06294197

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pelvic Floor Exercises
Description: In the intervention types, women are given training on pelvic floor exercises, that they can perform in the form of home exercises for 12 weeks. Before starting pelvic floor exercises therapy, a physiotherapist who specializes in pelvic floor compatibility will provide information about the location of the pelvic floor muscles through anatomical models and their effect on healthy, vaginal and sexual function. The effects of pelvic floor exercises on this system will be explained on an individual basis, and normal palpation is required to demonstrate their correct execution of contraction of the pelvic floor muscles. Participants will be taught how to contract and contract different muscles, such as the abdominal muscles, hip muscles, and gluteal muscles, or how to avoid pelvic tilt during contraction, and how to perform both rapid and sustained contractions.
Study: NCT04673045

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active Electrical stimulation
Description: The intensity of stimulation will be set within the subject's tolerance level. The amplitude was adjusted to produce muscle contraction without affecting the patient's comfort. The cathode electrode will be placed over the common peroneal nerve as it passes over the head of the fibula and the anode will be placed on mid-muscle belly on one third of the line between fibular head and medial malleolus on paretic limb.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Electrical Stimulation
Description: For sham group, the current intensity will gradually decreased after few seconds to 0. Therefore, the participant will experience a passage of current on the muscle at the beginning but received no current for the rest of the stimulation period. The participants will be informed that the stimulation below the sensory level.
Study: NCT06074627

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Energy Active Study Product 1.2 Usage
Description: Participants will use their Radicle Energy Active Study Product 1.2 as directed for a period of 6 weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Energy Active Study Product 1.3 Usage
Description: Participants will use their Radicle Energy Active Study Product 1.3 as directed for a period of 6 weeks.
Study: NCT06544564

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Membrane-Wrap Lite™
Description: Membrane- Wrap Lite™
Study: NCT04843358

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Emotional Disclosure
Description: The trial member will deliver instructions For the next three days, I want you to write about your experience with cancer. In your writing, I want you to really let go and explore your very deepest emotions and thoughts. It is critical that you delve deeply. Ideally, I would like you to write about those parts of the experience you found hard to share with others. Perhaps this will provide an opportunity to really examine those thoughts and emotions. You might tie your personal experiences to other parts of your life. How is it related to your family life, relationship with your spouse, your children, your sexuality, daily activities, hobbies, your past, your childhood, your work? These are just some examples.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Non-Emotional Writing
Description: The trial member will deliver instructions were as follows. For the next three days, I want you to write about how you use your time. We are interested in everything you do during the course of a day. In your writing I want you to be completely objective. We are not interested in your emotions or opinions. Feel free to be as detailed as possible
Study: NCT05005767

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: scaling and root planing
Description: will receive scaling and root planing only

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: scaling and root planing
Description: will receive scaling and root planing only

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Frankincense extract gel natural herbal product
Description: will receive Scaling and root planing then. Subgingival application of Frankincense extract gel
Study: NCT06544564

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CT-Shield™
Description: CT-Shield™

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Membrane Wrap™
Description: Membrane Wrap™

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Membrane Wrap - Hydro™
Description: Membrane Wrap - Hydro™

Intervention type: OTHER
Group type: OTHER
Intervention: Standard of Care
Description: SOC treatment will be defined as: 1) debridement of non-viable, necrotic tissue, 2) application of Biologic as the primary, wound covering, 3) application of a dressing over Biologic that maintains moisture balance, 4) application of a Class 3 high compression system, and 5) wrapping with a covering dressing
Study: NCT06183983

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Extended MRI
Description: The MRI-protocol before radiotherapy is extended with 20 minutes.
Study: NCT05563935

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Repetitive transcranial magnetic stimulation
Description: The OCD group will receive rTMS treatment for 6 weeks. There are 5 rTMS treatments per week (Monday to Friday), and 30 rTMS treatments in total. Treatment is administered by Ma GPro X100 device (Maga Venture) with Cool-DB80 coil. Detailed parameters of rTMS: intensity of stimulus is 120% RMT; the frequency of trains is 1Hz and the number of pulses is 1; no intertrain intervals and the pulses number is 1000.
Study: NCT06305260

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Lumbar Ultrasound
Description: Investigators will utilize our ultrasound machine to complete a pre-procedural lumbar ultrasound prior to epidural placement.
Study: NCT04789057

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 Mg Oral Tablet
Description: p.o., once daily

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: p.o., once daily
Study: NCT04347655

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: handgrip test
Description: The patient will be supine for at least 5 minutes to collect baseline data before being handed a dynamometer device. The subject will then be asked to squeeze the dynamometer with maximum force for a minimum of 2 minutes while only engaging their forearm and remaining relaxed in the rest of their body. The subject will then release the dynamometer and remain supine, in recovery, for a minimum of 5 minutes.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: handgrip test
Description: The patient will be supine for at least 5 minutes to collect baseline data before being handed a dynamometer device. The subject will then be asked to squeeze the dynamometer with maximum force for a minimum of 2 minutes while only engaging their forearm and remaining relaxed in the rest of their body. The subject will then release the dynamometer and remain supine, in recovery, for a minimum of 5 minutes.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: handgrip test
Description: The patient will be supine for at least 5 minutes to collect baseline data before being handed a dynamometer device. The subject will then be asked to squeeze the dynamometer with maximum force for a minimum of 2 minutes while only engaging their forearm and remaining relaxed in the rest of their body. The subject will then release the dynamometer and remain supine, in recovery, for a minimum of 5 minutes.
Study: NCT05208580

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual education
Description: Participants undergo virtual education activities on an on-line platform 10-14 days before the surgery

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Contact education
Description: Participants attend live educational classes 10-14 days before the surgery
Study: NCT06336512

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: ELISA
Description: Estimation of Zonulin by ELISA from the Blood samples which were obtained at time of pregnancy .
Study: NCT06189430

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Yoga
Description: Yoga practice was standardized throughout the study to avoid the risk of intervention variability. The basic structure of each yoga session is meditation, breathing exercises (pranayama), and after a warm-up, yoga practice includes asanas (postures) for strength, balance and mobility, and finally ends with relaxation. The yoga intervention we recommend was created within the framework of the asanas that the elderly can do in the literature and by taking the expert opinion of a sports physician.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard exercise
Description: It is a type of exercise similar in intensity to vinyasa yoga. (50-70% MHR: maximum pulse rate)
Study: NCT06443203

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Trimodal prehabilitation
Description: Trimodal prehabilitation program (4-week physical exercise before surgery, nutritional optimization, and psychological support) in patients undergoing ERAS colorectal resection for cancer
Study: NCT06107049

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: BLa80
Description: During the experiment, the subjects took a packet of probiotics every day, and the sleep condition, anxiety level and memory level of the subjects were evaluated by questionnaires and ability tests. The questionnaire included PSQI Pittsburgh Sleep Quality Index scale, ISI Insomnia Severity Index Scale and GSRS gastrointestinal symptom Score scale.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: BLa80
Description: During the experiment, the subjects took a packet of probiotics every day, and the sleep condition, anxiety level and memory level of the subjects were evaluated by questionnaires and ability tests. The questionnaire included PSQI Pittsburgh Sleep Quality Index scale, ISI Insomnia Severity Index Scale and GSRS gastrointestinal symptom Score scale.
Study: NCT04417569

Intervention type: DRUG
Intervention: hCG
Description: human chorionic gonadotropin

Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasound
Description: Endometrial thickness monitoring

Intervention type: OTHER
Intervention: Blood test
Description: Progesterone, Luteinizing Hormone, Estradiol
Study: NCT06395922

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Blockbuster LMA
Description: The LMA was inserted using the recommended technique, with the patient's head in the sniffing position. The appropriate size was selected based on body weight (size 3 for 30-50 kg, size 4 for 50-70 kg)

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Baska Mask
Description: The BM was inserted by opening the mouth, avoiding the tongue, and negotiating the palatopharyngeal curve using the hand-tab.
Study: NCT05733416

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: FDG PET/CT
Description: F-fluorodeoxyglucose positron emission/computed tomography

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Usual Care
Description: Cancer screening according to sex, age and risk as per Canadian Task Force on Preventative Health Care
Study: NCT05812586

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SCB-2019/Clover
Description: SCB-2019/Clover Vaccine

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SCB-2019/Clover
Description: SCB-2019/Clover Vaccine

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SCB-2019/Clover
Description: SCB-2019/Clover Vaccine

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AstraZeneca/Fiocruz
Description: AstraZeneca/Fiocruz Vaccine

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AstraZeneca/Fiocruz
Description: AstraZeneca/Fiocruz Vaccine

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AstraZeneca/Fiocruz
Description: AstraZeneca/Fiocruz Vaccine

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pfizer/Wyeth
Description: Pfizer/Wyeth Vaccine

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pfizer/Wyeth
Description: Pfizer/Wyeth Vaccine

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pfizer/Wyeth
Description: Pfizer/Wyeth Vaccine
Study: NCT06229249

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Carpal ligament self-myofascial stretching
Description: Carpal ligament self-myofascial stretching is a technique that involves applying pressure and stretching to the carpal ligaments and surrounding myofascial tissues of the wrist and hand. The objective is to release tension, improve flexibility, and alleviate discomfort or pain in the wrist and hand area.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional physical therapy
Description: In this technique, ultrasound therapy, nerve gliding exercise, tendon gliding exercise, and wrist splinting were performed.
Study: NCT06310083

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Submucosal Resection Turbinoplasty Versus Partial Inferior Turbinectomy
Description: The study's Participants Were Randomly classified in two groups Interventional Group, applied for Submucosal Resection Turbinoplasty and the controlled group who were applied for Partial Inferior Turbinectomy

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Submucosal Resection Turbinoplasty Versus Partial Inferior Turbinectomy
Description: The study's Participants Were Randomly classified in two groups Interventional Group, applied for Submucosal Resection Turbinoplasty and the controlled group who were applied for Partial Inferior Turbinectomy
Study: NCT06413264

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultrasonography guided Veress needle insertion for creating pneumoperitoneum
Description: A real-time visualisation of the path of the Veress needle entry by the use of high frequency (13-6 MHz) probe ultrasonography.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Veress needle will be inserted blindly as a closed technique for creating pneumoperitoneum
Description: The Veress needle is inserted blindly and guided by the resistance of tissues and the click sounds of layers of abdominal wall.
Study: NCT06039722

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pulse ablation catheter
Description: Pulse ablation catheter is used to ablate the junction of left atrium and pulmonary vein, removing pulmonary vein potential
Study: NCT04976530

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DrugSorb-ATR system
Description: Sorbent hemoperfusion system integrated into the cardiopulmonary bypass (CPB) circuit

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham comparator
Description: Sham comparator in similar position to the investigative device, but NOT integrated into the cardiopulmonary (CPB) circuit
Study: NCT06137911

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JYP0061
Description: JYP0061 orally administered

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JYP0061
Description: JYP0061 orally administered

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JYP0061
Description: JYP0061 orally administered

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Placebo orally administered

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Placebo orally administered

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Placebo orally administered
Study: NCT04393207

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine (LB)
Description: Transverse abdominis plane block will be performed and the neurofascial plane between the internal oblique and the transverse abdominis will be infiltrated with liposomal bupivacaine + bupivacaine or with bupivacaine alone.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone and methylprednisolone (CG)
Description: Transverse abdominis plane block will be performed and the neurofascial plane between the internal oblique and the transverse abdominis will be infiltrated with with bupivacaine alone.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone and methylprednisolone (CG)
Description: Transverse abdominis plane block will be performed and the neurofascial plane between the internal oblique and the transverse abdominis will be infiltrated with with bupivacaine alone.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Control group (Bupivacaine)- (BPG)
Description: Transverse abdominis plane block will be performed with plain bupivacaine
Study: NCT04792307

Intervention type: OTHER
Group type: OTHER
Intervention: Neuromuscular electrical stimulation , no high protein ice cream supplementation
Description: A trained operator applies Neuromuscular electrical stimulation treatment to one leg, for approximately 30 minutes per session, three sessions per week with or without high protein ice cream. Treatment can stimulate the nerve controlling the vastus lateralis muscle in the thigh or the nerve controlling the tibialis anterior muscle in the lower leg, or both. In our study, we will aim to stimulate both nerves and muscle groups, on the basis that the maximal effect with result from the maximal amount of muscle stimulated.Treatment is adjusted to generate a specific force and maintained for up to 5 minutes, followed by a rest period and then repeated three times over the typical 30-minute session. The stimulation can vary according to the frequency (pulses per second, typically 10-50Hz).~Additional protein supplementation: high protein ice cream :a single doses of a high protein supplement after each bout of neuromuscular electrical stimulation,

Intervention type: OTHER
Group type: OTHER
Intervention: Neuromuscular electrical stimulation , no high protein ice cream supplementation
Description: A trained operator applies Neuromuscular electrical stimulation treatment to one leg, for approximately 30 minutes per session, three sessions per week with or without high protein ice cream. Treatment can stimulate the nerve controlling the vastus lateralis muscle in the thigh or the nerve controlling the tibialis anterior muscle in the lower leg, or both. In our study, we will aim to stimulate both nerves and muscle groups, on the basis that the maximal effect with result from the maximal amount of muscle stimulated.Treatment is adjusted to generate a specific force and maintained for up to 5 minutes, followed by a rest period and then repeated three times over the typical 30-minute session. The stimulation can vary according to the frequency (pulses per second, typically 10-50Hz).~Additional protein supplementation: high protein ice cream :a single doses of a high protein supplement after each bout of neuromuscular electrical stimulation,
Study: NCT05012410

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Immediate treatment group with High-Intensity Prompts
Description: Caregivers in the immediate treatment group with high-intensity prompts will use the WeCareAdvisor tool for 6 months. Caregivers will receive telephone and email prompts to use the tool.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Immediate treatment group with Low-Intensity Prompts
Description: Caregivers in the immediate treatment group with low-intensity prompts will use the WeCareAdvisor tool for 6 months. Caregivers will receive email prompts to use the tool.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Waitlist Control after three months with High-Intensity Prompts
Description: After 3 months, caregivers will use the WeCareAdvisor tool for 3 months. Caregivers will receive telephone and email prompts. Once the caregiver receives the WeCareAdvisor tool, they will receive a weekly automated email as well as a weekly telephone call from study staff to prompt them to use the tool.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Waitlist Control after three months with Low-Intensity Prompts
Description: After 3 months, caregivers will use the WeCareAdvisor tool for 3 months. Caregivers will receive email prompts.
Study: NCT06320353

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RPH-075
Description: 100 mg/4 mL (25 mg/mL) concentrate for solution for infusions in a single-dose vial~The required volume (8 ml) of the Drug concentrate solution should be withdrawn from the vials and transferred into an intravenous bag containing 0.9% Sodium Chloride Injection or 5% Dextrose Injection. (The final concentration of the diluted solution should be between 1 mg/mL to 10 mg/mL.)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Keytruda®
Description: 100 mg/4 mL (25 mg/mL) concentrate for solution for infusions in a single-dose vial~The required volume (8 ml) of the Drug concentrate solution should be withdrawn from the vials and transferred into an intravenous bag containing 0.9% Sodium Chloride Injection or 5% Dextrose Injection. (The final concentration of the diluted solution should be between 1 mg/mL to 10 mg/mL.)
Study: NCT06326879

Intervention type: OTHER
Intervention: No intervention
Description: Questionnaires compilation and sample collection

Intervention type: OTHER
Intervention: No intervention
Description: Questionnaires compilation and sample collection